Showing results (1611-1620 of 1,950) with videos related to

Sort By:
Pageof 195
Investigational New Drugs|March 4, 2005
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, H Hirte, W H Miller, et al.
Journal of Medicinal Chemistry|March 14, 2007
Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitorsZhi-Fu Tao, Le Wang, Kent D Stewart, et al.
Insights Into Imaging|August 7, 2025
Pulmonary cysts as a diagnostic indicator of Birt-Hogg-Dubé syndrome in patients with renal neoplasmAmreen Shakur, Grant D Stewart, Timothy J Sadler, et al.
European Urology Oncology|August 20, 2025
Prevalence of Kidney Cancer in Attendees for Combined Lung and Kidney Cancer Screening by Computed Tomography ScanningSabrina H Rossi, Jessica Kitt, Angela Godoy, et al.
Biochemical Pharmacology|October 5, 2010
DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditionsGrant D Stewart, Jyoti Nanda, Elad Katz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2013
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancerT Powles, I Kayani, K Sharpe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2014
Pregnancy intentions among women living with HIV in the United StatesLisa Rahangdale, Amanda Stewart, Robert D Stewart, et al.
Thorax|October 15, 2021
Metabolomic differences in lung function metrics: evidence from two cohortsRachel S Kelly, Isobel D Stewart, Haley Bayne, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 8, 2022
A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screeningRebecca A Dennison, Rachel A Boscott, Rae Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC A Townsley, K Chi, D S Ernst, et al.
Pageof 195